Loading live market data…

Denali Therapeutics Inc.

NASDAQ:DNLI

$22.65 USD

-$3.83 (-14.46%)

Volume
5.78M
Average Volume
1.83M
Market Capitalization
$3.59B
P/E Ratio
-7.86
Dividend Yield
0.00%
Price Target
$35.00
Year High
$27.30
Year Low
$12.58
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$9.28

DNLI Estimated and Actual Revenue by Quarter

DNLI Estimated and Actual EPS by Quarter

DNLI Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 4 -120.02M -2.64M -17.28M -135.64M -2.99M -19.53M
2028-09-30 9 -102.41M -2.25M -14.75M -115.75M -2.55M -16.67M
2028-06-30 6 -84.93M -1.87M -12.23M -95.99M -2.11M -13.82M
2028-03-31 4 -67.58M -1.49M -9.73M -76.37M -1.68M -11M
2027-12-31 5 -21.26M -467.91K -3.06M -24.03M -528.83K -3.46M
2027-09-30 9 -16.03M -352.77K -2.31M -18.12M -398.7K -2.61M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 4 -2.19M 188.61M 21.61M 32.43M 1.47B 212.19M
2028-09-30 9 -295.01K 25.41M 2.91M 27.67M 1.26B 181.06M
2028-06-30 6 -201.48M 2.34M -23.09M 22.95M 1.04B 150.16M
2028-03-31 4 -409.96M 4.76M -46.98M 18.26M 829.6M 119.47M
2027-12-31 5 -791.37M 9.19M -90.68M 5.74M 260.99M 37.59M
2027-09-30 9 -947.67M 11M -108.59M 4.33M 196.77M 28.34M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 4 33.98M 1.54B 222.35M 5 -0.01173328 1.01058 0.1158
2028-09-30 9 29M 1.32B 189.73M 10 -0.00158065 0.13614 0.0156
2028-06-30 6 24.05M 1.09B 157.35M 7 -1.07952 0.01253374 -0.1237
2028-03-31 4 19.13M 869.32M 125.19M 5 -2.19657 0.02550316 -0.2517
2027-12-31 5 6.02M 273.49M 39.39M 4 -4.24016 0.04923012 -0.48587
2027-09-30 9 4.54M 206.2M 29.69M 8 -5.0776 0.05895314 -0.58183